Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anthroposophic supportive medicine in children receiving chemotherapy for cancer
2004-002711-83Phase 4Completed
- Sponsor
- Helixor Heilmittel GmbH
- Start
- Jun 2005
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of viscum album extract in cancer, leukemia, lymphoma and 1 more, sponsored by Helixor Heilmittel GmbH. Primary endpoint: Score of side effects during the intensive phase of chemotherapy. Started Jun 2005; status: completed.
02
Drugs
viscum album extract
03
Conditions
cancerleukemialymphomaNonhematologic neoplasms
Beyond the preview
Go deeper on 2004-002711-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002711-83.